NCT02373917View on ClinicalTrials.gov

Characterization of Methylation Patterns in Lung Cancer

CompletedOBSERVATIONAL
Enrollment

683

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Lung Cancer
Trial Locations (1)

Unknown

Sha'are Tzedaek Medical Center, Jerusalem

Sponsors

Lead Sponsor

Nucleix Ltd.
All Listed Sponsors
lead

Nucleix Ltd.

INDUSTRY

NCT02373917 - Characterization of Methylation Patterns in Lung Cancer | Biotech Hunter | Biotech Hunter